Sean E Harper Amgen Inc (AMGN) insider trading activity

Sean E Harper is EVP, Research & Development of AMGEN INC. Currently has a direct ownership of 56,082 shares of AMGN, which is worth approximately $17.8 Million. The most recent transaction as insider was on Jul 16, 2018, when has been sold 1,525 shares (Common Stock) at a price of $195.71 per share, resulting in proceeds of $298,458. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.1K

0% 3M change

0% 12M change

Total Value Held $17.8 Million

Sean E Harper Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 16 2018	SELL Open market or private sale	$298,458 $195.71 p/Share	1,525 Reduced 2.65%	56,082 Common Stock
Jun 12 2018	SELL Open market or private sale	$281,012 $184.27 p/Share	1,525 Reduced 2.58%	57,510 Common Stock
May 14 2018	SELL Open market or private sale	$265,503 $174.1 p/Share	1,525 Reduced 2.52%	59,035 Common Stock
May 03 2018	SELL Payment of exercise price or tax liability	$124,700 $169.43 p/Share	736 Reduced 1.2%	60,560 Common Stock
Apr 27 2018	BUY Grant, award, or other acquisition	-	4,508 Added 6.85%	61,296 Common Stock
Apr 12 2018	SELL Open market or private sale	$263,337 $172.68 p/Share	1,525 Reduced 2.62%	56,788 Common Stock
Mar 23 2018	SELL Payment of exercise price or tax liability	$1,329,228 $176.08 p/Share	7,549 Reduced 11.46%	58,313 Common Stock
Mar 16 2018	SELL Open market or private sale	$289,369 $189.75 p/Share	1,525 Reduced 2.27%	65,682 Common Stock
Mar 07 2018	BUY Grant, award, or other acquisition	-	15,118 Added 18.36%	67,207 Common Stock
Feb 14 2018	SELL Open market or private sale	$265,624 $174.18 p/Share	1,525 Reduced 2.84%	52,089 Common Stock
Jan 31 2018	SELL Payment of exercise price or tax liability	$115,910 $191.27 p/Share	606 Reduced 1.12%	53,614 Common Stock
Jan 30 2018	SELL Payment of exercise price or tax liability	$89,694 $198.0 p/Share	453 Reduced 0.83%	54,200 Common Stock
Jan 16 2018	SELL Open market or private sale	$283,070 $185.62 p/Share	1,525 Reduced 2.71%	54,673 Common Stock
Dec 12 2017	SELL Open market or private sale	$269,666 $176.83 p/Share	1,525 Reduced 2.65%	56,106 Common Stock
Nov 13 2017	SELL Open market or private sale	$261,660 $171.58 p/Share	1,525 Reduced 2.58%	57,631 Common Stock
Oct 09 2017	SELL Open market or private sale	$283,574 $185.95 p/Share	1,525 Reduced 2.51%	59,156 Common Stock
May 01 2017	BUY Grant, award, or other acquisition	-	4,551 Added 7.0%	60,496 Common Stock
Mar 24 2017	SELL Payment of exercise price or tax liability	$2,013,733 $166.04 p/Share	12,128 Reduced 17.82%	55,945 Common Stock
Mar 07 2017	BUY Grant, award, or other acquisition	-	23,092 Added 25.39%	67,866 Common Stock
Jan 31 2017	SELL Payment of exercise price or tax liability	$103,159 $154.43 p/Share	668 Reduced 1.47%	44,774 Common Stock
Jan 30 2017	SELL Payment of exercise price or tax liability	$80,623 $157.16 p/Share	513 Reduced 1.12%	45,442 Common Stock
Jan 28 2017	SELL Payment of exercise price or tax liability	$165,961 $157.16 p/Share	1,056 Reduced 2.25%	45,955 Common Stock
May 03 2016	BUY Grant, award, or other acquisition	-	4,477 Added 8.74%	46,725 Common Stock
Apr 29 2016	SELL Open market or private sale	$3,456,031 $157.99 p/Share	21,875 Reduced 34.11%	42,248 Common Stock
Apr 27 2016	SELL Payment of exercise price or tax liability	$270,168 $162.85 p/Share	1,659 Reduced 2.52%	64,123 Common Stock

SEH

Sean E Harper

EVP, Research & Development

Thousand Oaks, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMGN shares.

Notify only if

Value

Insider Trading

Get notified when an Amgen Inc insider buys or sells AMGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMGEN INC

Track Activities on AMGN

Account